0001209191-22-037409.txt : 20220616
0001209191-22-037409.hdr.sgml : 20220616
20220616162133
ACCESSION NUMBER: 0001209191-22-037409
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220614
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KANEKO YASUNORI
CENTRAL INDEX KEY: 0001277503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 221020843
MAIL ADDRESS:
STREET 1: 509 ROEHAMPTON
CITY: HILLS BOROUGH
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-14
0
0001724521
Arcus Biosciences, Inc.
RCUS
0001277503
KANEKO YASUNORI
C/O ARCUS BIOSCIENCES, INC.
3928 POINT EDEN WAY
HAYWARD
CA
94545
1
0
0
0
Common Stock
2022-06-14
4
A
0
4100
0.00
A
4100
D
Common Stock
505050
I
By Kaneko Capital, LLC
Common Stock
252524
I
By Kaneko Investments, LLC
Common Stock
142081
I
By Trust
Stock Option (Right to Buy)
20.62
2022-06-14
4
A
0
16800
0.00
A
2032-06-13
Common Stock
16800
16800
D
Represents the grant of restricted stock units that vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
Includes 3,000 shares of restricted stock units (previously reported) that vested on June 3, 2022 and were subsequently transferred to the reporting person's trust.
The option will vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.
/s/ Carolyn Tang, Attorney-in-Fact
2022-06-16